Company Filing History:
Years Active: 2021-2022
Title: Tae Hun Ku: Innovator in Pharmaceutical Compositions
Introduction
Tae Hun Ku is a notable inventor based in Busan, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in compositions aimed at treating various health conditions. With a total of 2 patents, his work focuses on innovative solutions for cancer treatment and inflammatory diseases.
Latest Patents
One of Tae Hun Ku's latest patents is a composition for preventing or treating cancer. This invention provides a pharmaceutical composition that not only aims to prevent or treat cancer but also enhances immune functions and addresses cachexia caused by tumors. The composition is designed to inhibit tumor growth, increase immunological activity, and can achieve a synergistic effect when co-administered with existing anticancer drugs.
Another significant patent involves methods for treating inflammatory diseases. This invention includes a composition containing active ingredients for antitussive, expectorant, or anti-inflammatory actions. The compositions are derived from natural materials and exhibit minimal cytotoxicity, making them safe for use as medicines or food compositions with antitussive, expectorant, and anti-inflammatory effects.
Career Highlights
Throughout his career, Tae Hun Ku has worked with various companies, including Okchundang Co., Ltd. and his own venture, Ku, Tae Hun. His experience in these organizations has contributed to his expertise in developing effective pharmaceutical compositions.
Collaborations
Tae Hun Ku has collaborated with notable individuals in his field, including Sae Kwang Ku and Seong Min Ku. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in healthcare.
Conclusion
Tae Hun Ku is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact the treatment of cancer and inflammatory diseases. His innovative approaches and collaborations highlight his commitment to advancing medical science.